FET PET for the Prediction of Response to Lomustine-Based Chemotherapy in Patients With Glioma Recurrence
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PET
Neuro-oncology 2022 Oct 10;[EPub Ahead of Print], MM Wollring, JM Werner, EK Bauer, C Tscherpel, GS Ceccon, P Lohmann, G Stoffels, C Kabbasch, R Goldbrunner, GR Fink, KJ Langen, N GalldiksFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.